Reporte zur Charge EN9166

Symptomtext

painful injection; dizzy; stomach burned; tongue felt numb; glands in throat hurt; flushed; slight headache; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number: EN9166, Expiration Date: not reported), via an unspecified route of administration, administered in right arm on 09Mar2021 at 10:45 (at the age of 70 years old) as dose 1, single for COVID-19 immunisation. The facility where the most recent COVID-19 vaccine was administered was reported to be "other". Medical history included high BP (blood pressure), high cholesterol and osteoporosis. The patient was not pregnant at the time of vaccination and prior to vaccination was not diagnosed with COVID-19. Concomitant medications included olmesartan; nifedipine; colesevelam hydrochloride (WELCHOL); ezetimibe (ZETIA) and aspirin [acetylsalicylic acid] - all taken for an unspecified indication, start and stop date were not reported. The patient previously took erythromicin (ERYTHROMYCIN), nitrofurantoin (MACRODANTIN), oxycodone (OXYCODON) and barium Sulfate contrast (IVP dye) - all taken for an unspecified indication on an unspecified date and experienced allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 09Mar2021 at 10:45, the patient experienced painful injection, dizzy, stomach burned (as reported), tongue felt numb, glands in throat hurt (as reported), was flushed and slight headache. All events resulted to Doctor or other healthcare professional office/clinic visit. No treatment was received for the adverse events. Since vaccination, the patient has not been tested for COVID-19. Outcome of all events was recovered on an unspecified date. No follow-up attempts are needed. No further information is expected.